This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CME Group (CME) Q3, September Volumes Up in Two Product Lines
by Zacks Equity Research
CME Group's (CME) Q3 average daily volumes reflect higher volumes in two of the six product lines.
MarketAxess (MKTX) Down 26% This Year: What Ails the Stock?
by Zacks Equity Research
Weakness in bond trading volumes is likely to keep MarketAxess Holdings' (MKTX) revenues in check.
Cboe Global (CBOE) Subsidiary to Unveil Algo Execution
by Zacks Equity Research
Cboe Global's (CBOE) subsidiary set to launch an algorithmic execution service to boost the Global FX segment.
MarketAxess (MKTX) Trading Volumes Down on Low Market Volatility
by Zacks Equity Research
MarketAxess' (MKTX) trading volumes this year lag the past-year levels due to low market volatility, which might limit its top-line growth.
Cboe Global (CBOE) August Volume Increases Year Over Year
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures, European Equities, and global forex volumes reflect year-over-year increases in August, offset by lower Canadian Equities.
Cboe Global (CBOE) Stock Up 37% YTD: More Room for Upside?
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products, and solid capital position continue to drive Cboe Global (CBOE).
Here's Why You Should Stay Away From MarketAxess (MKTX) Now
by Zacks Equity Research
Weakness in trading volumes weighs on MarketAxess (MKTX), causing an overall pessimistic scenario for the stock.
Cboe Global (CBOE) to Share More Profits, Ups Dividend by 14%
by Zacks Equity Research
Cboe Global's (CBOE) recent dividend hike reflects its intention to enhance shareholders' value supported by strong financial position.
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Nasdaq and OTC Markets Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Cboe Global Markets, CME Group, Nasdaq and OTC Markets Group
4 Securities and Exchanges to Watch Out For Amid Industry Challenges
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CBOE, CME, NDAQ and OTCM. However, compliance with regulations remains a challenge.
Coinbase Global (COIN) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Coinbase Global's (COIN) Q2-quarter results are likely to benefit from increased adoption of a greater number of crypto assets, and increased volatility coupled with increased interest across the entire cryptoeconomy.
Cboe Global (CBOE) Q2 Earnings and Revenues Top, Rise Y/Y
by Zacks Equity Research
Cboe Global (CBOE) Q2 results reflect robust trading in proprietary index products and demand for data and access solutions products.
CBOE Global (CBOE) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 2.22% and 1.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Q2 Earnings Beat, Revenues Decrease Y/Y
by Zacks Equity Research
CME Group's (CME) Q2 results reflect higher market data and information services and lower expenses as well as increase in average daily volume in four of the six products lines.
What Awaits Cboe Global Markets (CBOE) This Earnings Season?
by Zacks Equity Research
CBOE Global's (CBOE) second-quarter performance is likely to have benefited from multi-listed options and continued growth in recurring non-transaction revenues, as well as contribution from acquisitions.
CBOE Global (CBOE) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MarketAxess (MKTX) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
MarketAxess' (MKTX) Q2 earnings and revenues beat estimates but decline year over year due to low trading volumes and high expenses.
Nasdaq (NDAQ) Surpasses Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Nasdaq's (NDAQ) second-quarter results reflect organic growth, favorable changes in foreign exchange rates, margin expansion and solid segmental performance.
Will Lower Trading Volume Mar MarketAxess (MKTX) Q2 Earnings?
by Zacks Equity Research
Soft trading volumes and high expenses might dampen MarketAxess' (MKTX) Q2 results.
Here's Why MarketAxess (MKTX) is Not an Attractive Stock Now
by Zacks Equity Research
MarketAxess' (MKTX) long-term prospects look intact but short-term concerns with respect to low trading volumes and high expenses still persist.
MarketAxess (MKTX) Witnesses Q2 and June Volumes Decline
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter 2021 business volumes hint toward fall in U.S. high-grade and rates volumes, partly offset by higher trading across other credit products.
Intercontinental Exchange (ICE) Q2 Volumes Decrease Y/Y
by Zacks Equity Research
Intercontinental Exchange (ICE) reports soft average daily volume (ADV) for the second quarter due to lower volumes in Commodities, partly offset by higher Financials.
Cboe Global Markets (CBOE) Reports Mixed Q2 & June Volumes
by Zacks Equity Research
Cboe Global Markets (CBOE) reports mixed average daily volume (ADV) for the second quarter and June 2021
CME Group (CME) Q2 Volumes Increase Y/Y in Four Product Lines
by Zacks Equity Research
CME Group's (CME) Q2 average daily volumes reflect higher volumes in four of the six product lines.
You Have a Theory, Which Options Should You Choose?
by David Borun
Picking the right expiration cycle can be the difference between success and failure in the options markets.